Get started
Work

Identification and management of pathogenic mutations in BRCA1, BRCA2, and PALB2 in a tumor-only genomic testing program.

Year: 2021
Type: conference-abstract
DOI: 10.1200/jco.2021.39.15_suppl.10528
Authors: Brittany L. Bychkovsky, Tianyu Li, Jilliane Sotelo, Nabihah Tayob, Joanna Mercado, Israel Gomy, Anu B. Chittenden, Sarah R. Kane, Samantha Stokes, Melissa E Hughes, Ji Seok Kim, Mark M. Awad, Panagiotis A. Konstantinopoulos, Brian M. Wolpin, Mary-Ellen Taplin, Bruce E. Johnson, Neal Ian Lindeman, Laura E MacConaill, Judy Ellen Garber, Nancy U. Lin
Institutions: Harvard University, Dana-Farber Cancer Institute, Thermo Fisher Scientific (United States), Memorial Sloan Kettering Cancer Center, Dana-Farber/Harvard Cancer Center, Brigham and Women's Hospital
Language: English
Subfield: Genetics
Open Access status: closed
OpenAlex ID: W3168960037
Cites:
Cited by: 1
Related to: 10